(Press-News.org) Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the meta-analysis of data from the PROTECTED TAVR and BHF PROTECT TAVI Trials
Background
The embolisation of debris after transaortic valve implantation (TAVI) for the treatment of aortic stenosis can lead to stroke. Cerebral embolic protection (CEP) devices, which can capture this debris and thus lower the incidence of stroke, have been deployed during TAVI, however, results from their use have been seen as inconclusive.
Recent trials, such as the PROTECTED TAVR1 and BHF PROTECT-TAVI2 have demonstrated no significant difference between the control arm and the CEP arm within 72 hours after TAVI or TAVR.
The current meta-analysis presented by Prof. Rajesh Kharbanda combines the results of both trials to better understand these results and allow for more definitive research for the future use of CEP in these interventions.
Results
This meta-analysis combined individual patient data (IPD) of the 10,635 patients from both the PROTECTED TAVR (3,000 patients) and BHF PROTECT-TAVI (7,635 patients) trials – the largest randomised trials to date studying the use of a CEP during TAVI (in these trials, the SENTINEL™ device [Boston Scientific] was used).
This analysis focused on the modified intention-to-treat population (ITT) studying results of all the randomised patients whose TAVI procedures had started and included 5,293 in the “TAVI without CEP” arm and 5,287 in the “TAVI with CEP” arm.
The patient population of both arms were similar.
Mean age was 80.6 years in both groups with less than 40% women.
Surgical risk score, STS and EuroSCORE II were also similar in both groups, as was their medical history.
The primary analysis looked at the difference in incidence of stroke between the interventional (CEP) and control (no CEP) arms within 72 hours after TAVI or hospital discharge.
The combined results showed no evidence that a routine CEP strategy is effective in the modified ITT population in reducing overall stroke.
A secondary analysis considered the per-protocol population with the Complier Average Causal Effect (CACE) adjusting the ITT estimate due to non-adherence and showed similar results.
Key learnings
This meta-analysis confirmed that there was no reduction in periprocedural stroke after TAVI with CEP in the modified ITT population or for CEP after adjustment for non-adherence using CACE analysis.
Choice of device
SENTINEL™ device (Boston Scientific)
Conclusions and PCR recommendations
Despite a clear rationale leading to the development of CEP, this meta-analysis of individual data from 2 large RCTs (PROTECTED TAVR and BHF-PROTECT-TAVI) clearly demonstrated that there was no benefit of the routine use of CEP with the SENTINEL device during TAVI to reduce the risk of peri-procedural stroke.
The meta-analysis leads to several key points for future studies:
The need to better understand what failure to fully deploy a CEP device clinically implies.
Identification of any patient subgroups in which CEP may be beneficial.
The development of a risk prediction model to identify patients at highest risk of stroke after TAVI.
References
Kapadia SR, et al. Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement. N Engl J Med. 2022;387:1253-63. doi: 10.1056/NEJMoa2204961.
Kharbanda RK, et al. Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation. N Engl J Med. 2025 Mar 30. doi: 10.1056/NEJMoa2415120.
NOTES TO EDITORS
Key information
Session: Hotline /Late-Breaking Trials: Major Late-Breaking Trials from EuroPCR 2025
Presentation: Meta-Analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies
Presenter: Rajesh Kharbanda
Palais des Congrès Porte Maillot – Paris, France
21 May 2025 11:15 - 12:15 in the Theatre Bleu END
EuroPCR 2025 – Meta-analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI trials
2025-05-21
ELSE PRESS RELEASES FROM THIS DATE:
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
2025-05-21
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the FAITAVI randomised clinical trial (RCT).
Background
The optimal management of patients with intermediate coronary artery disease (CAD) and severe aortic stenosis (AS) who are candidates for TAVI remains unclear. Recent trials comparing percutaneous coronary intervention ...
EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
2025-05-21
Background
While dual antiplatelet therapy (DAPT) has long been the standard of care for the management of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), there is an increasing awareness of the need to find a more patient-centred approach that strikes a balance between the ischaemic protection DAPT offers and the risk of bleeding complications it can create.
The effect of DAPT in dosage and duration on cardiovascular events and bleeding after implantation of drug-coated stents (DCS) in ACS patients, ...
PREVENT equation accurately estimated 10-year CVD risk and those with calcium buildup
2025-05-21
Research Highlights:
The American Heart Association’s PREVENTTM risk calculator accurately identified participants who had calcium buildup in their heart arteries and those who had a higher future heart attack risk, in an analysis of about 7,000 adults in New York City referred for heart disease screening.
The PREVENT scores also predicted future heart attack risk.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, May 21, 2025
DALLAS, May 21, 2025 — The PREVENTTM risk calculator helped to identify people with plaque buildup in the arteries of the heart, in addition to predicting their risk of a future heart attack, according ...
Nano-engineered thermoelectrics enable scalable, compressor-free cooling
2025-05-21
Researchers at the Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, have developed a new, easily manufacturable solid-state thermoelectric refrigeration technology with nano-engineered materials that is twice as efficient as devices made with commercially available bulk thermoelectric materials. As global demand grows for more energy-efficient, reliable and compact cooling solutions, this advancement offers a scalable alternative to traditional compressor-based refrigeration.
In a paper published in ...
Researchers identify a dual origin of cells controlling puberty and reproduction
2025-05-21
Researchers at the Francis Crick Institute have shown that gonadotrophs, cells in the pituitary gland with a key role in puberty and reproduction, come from two different populations, with the majority produced after birth rather than in the embryo, as previously thought.
A better understanding of when these important cells develop could help researchers and clinicians understand and treat disorders that impact puberty and fertility.
In the pituitary, a small gland located in the middle of the head and connected to the brain, gonadotrophs ...
Major step for flat and adjustable optics
2025-05-21
By carefully placing nanostructures on a flat surface, researchers at Linköping University, Sweden, have significantly improved the performance of so-called optical metasurfaces in conductive plastics. This is a major step for controllable flat optics, with future applications such as video holograms, invisibility materials, and sensors, as well as in biomedical imaging. The study has been published in the journal Nature Communications.
To control light, curved lenses are used today, that are often made of glass that is either concave or convex, ...
Less frequent stroke monitoring is safe, effective, and frees up resources, study finds
2025-05-21
Halving the number of times vital signs and neurological function are checked in low-risk patients after treatment for acute ischaemic stroke does not compromise care or recovery, according to new findings presented at the 11th European Stroke Organisation Conference in Helsinki, Finland.
Results from the Optimal Post rTpa-Iv Monitoring in Ischaemic Stroke Trial (OPTIMISTmain)1, simultaneously published in The Lancet, also showed that this approach also had flow-on benefits for nursing workflow and intensive care resources. The trial was led by Professor Craig Anderson from The George Institute for Global Health and UNSW ...
Living tattoos for buildings
2025-05-21
External walls of buildings are normally lifeless and have no additional function. An international team of researchers and companies, in which Carole Planchette from the Institute of Fluid Mechanics and Heat Transfer is involved, wants to change this by adding microbial life to building façades. In the project “Archibiome tattoo for resistant, responsive, and resilient cities” (REMEDY), the consortium is working on integrating specifically composed communities of beneficial microorganisms into ...
Could strawberry tree extract prevent and treat gastrointestinal disorders?
2025-05-21
New research in rats indicates that a Mediterranean plant may be an effective treatment for ulcerative colitis, a type of inflammatory bowel disease. The findings are published in the Journal of the Science of Food and Agriculture.
Various antioxidant and anti-inflammatory medications are used to treat ulcerative colitis, but they can cause numerous side effects. To test the potential of the Arbutus unedo plant (often referred to as the strawberry tree) that is native to the Mediterranean region, investigators gave rats doses of an extract from the plant ...
Can engaging in social activities prolong life?
2025-05-21
A study in the Journal of the American Geriatrics Society indicates that social engagement may help older individuals live longer.
In the study of 2,268 U.S. individuals aged 60 years and older who completed the Psychosocial and Lifestyle Questionnaires and provided blood samples in 2016, there was a strong association between engaging in social activities and a low risk of 4-year mortality. High social engagement was associated with a 42% lower mortality risk than low engagement.
Specific activities, such as charity work, engaging with grandchildren, and participation in sports or social clubs, were particularly significant predictors of a reduced risk ...